Reporter : Chen Cong / Publisher : XinhuaNet via ScienceNet
Ref : http://news.sciencenet.cn/htmlnews/2020/8/444367.shtm
Translation, editing : Gan Yung Chyan, KUCINTA SETIA
The reporter learned from the National Health Commission on 19 August 2020 that the General Office of the National Health Commission and the Office of the State Administration of Traditional Chinese Medicine issued the "Novel Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Eighth) Version".
Guo Yanhong, Inspector General of the Medical Administration and Hospital Administration of the National Health Commission, said that in the revision and improvement of the diagnosis and treatment plan, they sum up clinical experience on the one hand, and continuously optimize the diagnosis and treatment measures on the other hand, so that the diagnosis and treatment plan can be more scientific, accurate and complete. More comprehensive, and better provide guidelines and a standardized framework for improving the treatment of covid are available.
Specifically, in terms of epidemiological characteristics, the eighth edition of the diagnosis and treatment plan clarifies that "the source of infection is mainly patients with novel coronavirus infection and asymptomatic infections. They are infectious during the incubation period and are highly infectious within 5 days after the onset of disease." The expression of the source of infection and the route of transmission has been further improved, and the expression "contact with virus-contaminated items can also cause infection" has been added.
In terms of treatment, the eighth edition of the diagnosis and treatment plan proposes that "lopinavir/ritonavir and ribavirin alone are not recommended, hydroxychloroquine or combined use of azithromycin is not recommended", and the treatment of severe and critical cases The specific content of "airway management" and "anticoagulation therapy" has been added.
No comments:
Post a Comment